Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)

Pim Hendriks(Leiden University Medical Center), Roel J. Bennink(Amsterdam University Medical Centers), Frits Smit(Leiden University Medical Center), Arian R. van Erkel(Leiden University), Maarten E. Tushuizen(Leiden University Medical Center), Carla van Rijswijk(Leiden University Medical Center), Stijn Crobach(Leiden University Medical Center), Mark Arntz(Radboud University Nijmegen), Joey Roosen(Radboud University Nijmegen), Lioe‐Fee de Geus‐Oei(Leiden University Medical Center), R. Bart Takkenberg(Amsterdam University Medical Centers), Daphne D. D. Rietbergen(Amsterdam University Medical Centers), Otto M. van Delden(Amsterdam UMC Location University of Amsterdam), Minneke J. Coenraad(Leiden University Medical Center), Heinz‐Josef Klümpen(University Medical Center Groningen), Mette K. Stam(Leiden University Medical Center), R.W. van der Meer(Leiden University Medical Center), J. Frank W. Nijsen, Bastian N. Ruijter(Leiden University Medical Center), Andries E. Braat(Leiden University Medical Center), Petra Dibbets‐Schneider(Leiden University Medical Center), Floris H. P. van Velden(Leiden University Medical Center), Mark C. Burgmans(Leiden University Medical Center), Tom van der Hulle
European Journal of Nuclear Medicine and Molecular Imaging
February 8, 2024
Cited by 8


Related Papers